drugset / Trial / NCT00003846

Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors

NCT00003846

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Radiation therapy uses x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Peripheral stem cell transplantation may allow doctors to give higher doses of radiation therapy and chemotherapy and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of radiation therapy, chemotherapy and peripheral stem cell transplantation in treating patients with primitive neuroectodermal tumors.

Timeline

Start
1999-07
Primary completion
2004-10
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Thiotepa Other / unclassified Intravenous
Background Carboplatin Small molecule Intravenous
Background Cyclophosphamide Other / unclassified Intravenous
Background Vincristine Small molecule Intravenous
Background filgrastim Protein / enzyme biologic Subcutaneous